The one exception was speech or language disorders, for which maternal infection was linked to double the risk. Continue Reading »

A new study highlights the factors that keep vaccine-willing adults from getting immunized. Continue Reading »

Symptoms that persist for three months or more are also common after other respiratory viral infections like the flu and RSV. Continue Reading »

Participants who met physical activity recommendations before infection had a 20% lower rate of functional disability 2 years later than those who didn’t. Continue Reading »

Things no longer reliably provided by the CDC: What vaccines are recommended, whether you can walk in and get one, and what's happening with disease in the US. Continue Reading »

A new study sheds light on the immune cells responsible for producing autoantibodies in people with COVID. Continue Reading »

A family in Lancaster County lost a newborn and then heard the HHS secretary suggest their child's death might have been invented. They deserve better. Continue Reading »

The groups, along with other leading US medical organizations, offer vaccine recommendations for the upcoming respiratory illness season.  Continue Reading »

Our researchers systematically reviewed the newest scientific evidence on flu, COVID-19, and RSV immunizations, examining effectiveness and safety. Continue Reading »

The trial found that taking the drug for 25 days was no better than placebo in improving exercise intolerance and cognitive and other symptoms. Continue Reading »

Risk was about 25% lower with early initiation in infected patients with either chronic disease who received supplemental oxygen. Continue Reading »

Measles offers a clean example of what a high-risk-versus-no-risk dichotomy misses.The virus can erase immune memory, among other serious consequences. Continue Reading »

No ties were established between persistent symptoms and cesarean delivery, NICU admission, or low birth weight. Continue Reading »

The FDA has approved updated COVID vaccines for adults over age 65 and younger people with chronic conditions. Continue Reading »

Affected workers described support from the National Health Service as ‘inconsistent and insufficient.’ Continue Reading »

Being unvaccinated and getting COVID-19 were associated with a higher risk of heart disease and death than receiving a vaccine. Continue Reading »

Obstetric risk evolved across variant periods, underscoring the need for ongoing maternal health surveillance and adaptive healthcare policies. Continue Reading »

Vaccination rates differed significantly by education level and age, and reasons for remaining unvaccinated differed by race and education level. Continue Reading »

Scientists say younger age and lower rates of chronic conditions are probably not the driving factors. Continue Reading »

Experts say people who want the vaccines will be able to access them, and insurance will cover them. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 August - 4 September, and includes updates on Ebola, SARS-CoV-2 variant classification, West Nile virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, vibrio, Middle East respiratory syndrome, malaria, ... Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22 - 28 August, and includes updates on diphtheria, Ebola, swine influenza A(H1N2), respiratory virus epidemiology, Crimean-Congo haemorrhagic fever, dengue, chikungunya virus disease, Vibrio growth, West Nile ... Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 August 2026, and includes updates on Ebola, respiratory virus epidemiology in the EU/EEA, swine flu, West Nile virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, vibrio, influenza, Dermatophilosis ... Continue Reading »

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2. Continue Reading »

Today ECDC published new guidance on respiratory virus surveillance for the EU/EEA. Continue Reading »

This document is the main module of a suite of documents that together comprise guidance for integrated respiratory virus surveillance in the EU/EEA. Continue Reading »

This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2025 and 27 March 2026, with some variation in reporting dates between countries. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 June - 3 July 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, expert deployment, Middle East respiratory syndrome (MERS), Vibrio, and ... Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19 - 26 June 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, Influenza A(H9N2), cholera, mpox, dengue, expert deployment, travel-associated chikungunya virus ... Continue Reading »

This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line ... Continue Reading »